Found 5 results
Name | Type of Offering | Accepted Date |
---|---|---|
Unicycive Therapeutics, Inc.
See All Filings
|
D | 2019-08-16 16:45:56 |
Amount To Be Raised
$526,950
Associated Brokers / Dealers
N/A
CIK Number
0001766140
Filed Document
0001213900-19-016191
Exclusions or Exemptions
506b
Accepted Date
2019-08-16 16:45:56
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Unicycive Therapeutics, Inc.
See All Filings
|
D | 2019-03-04 16:19:17 |
Amount To Be Raised
$420,000
Associated Brokers / Dealers
N/A
CIK Number
0001766140
Filed Document
0001213900-19-003518
Exclusions or Exemptions
506b
Accepted Date
2019-03-04 16:19:17
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Unicycive Therapeutics, Inc.
See All Filings
|
D | 2024-03-20 17:09:44 |
Amount To Be Raised
$50,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001766140
Filed Document
0001213900-24-024422
Exclusions or Exemptions
506b
Accepted Date
2024-03-20 17:09:44
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Unicycive Therapeutics, Inc.
See All Filings
|
D | 2020-06-03 17:17:52 |
Amount To Be Raised
$604,140
Associated Brokers / Dealers
N/A
CIK Number
0001766140
Filed Document
0001213900-20-014033
Exclusions or Exemptions
506b
Accepted Date
2020-06-03 17:17:52
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Unicycive Therapeutics, Inc.
See All Filings
|
D | 2023-03-13 16:46:09 |
Amount To Be Raised
$30,190,000
Associated Brokers / Dealers
N/A
CIK Number
0001766140
Filed Document
0001213900-23-019602
Exclusions or Exemptions
506b
Accepted Date
2023-03-13 16:46:09
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|